Associations	O
of	O
Body	B:C1305855
Mass	I:C1305855
Index	I:C1305855
and	O
Physical	O
Activity	O
With	O
Sexual	O
Dysfunction	I:C0549622
in	O
Breast	O
Cancer	I:C0678222
Survivors	O
.	O

Associations	O
of	O
Body	O
Mass	I:C1305855
Index	I:C1305855
and	O
Physical	O
Activity	O
With	O
Sexual	B:C0549622
Dysfunction	I:C0549622
in	O
Breast	O
Cancer	I:C0678222
Survivors	O
.	O

Associations	O
of	O
Body	O
Mass	I:C1305855
Index	I:C1305855
and	O
Physical	O
Activity	O
With	O
Sexual	O
Dysfunction	I:C0549622
in	O
Breast	B:C0678222
Cancer	I:C0678222
Survivors	O
.	O

Sexual	B:C0549622
dysfunction	I:C0549622
is	O
a	O
common	O
and	O
distressing	O
consequence	O
of	O
breast	O
cancer	I:C0678222
(	O
breast	O
cancer	I:C0678222
)	O
treatment	O
.	O

Sexual	O
dysfunction	I:C0549622
is	O
a	O
common	O
and	O
distressing	B:C0231303
consequence	O
of	O
breast	O
cancer	I:C0678222
(	O
breast	O
cancer	I:C0678222
)	O
treatment	O
.	O

Sexual	O
dysfunction	I:C0549622
is	O
a	O
common	O
and	O
distressing	O
consequence	O
of	O
breast	B:C0678222
cancer	I:C0678222
(	O
breast	O
cancer	I:C0678222
)	O
treatment	O
.	O

Sexual	O
dysfunction	I:C0549622
is	O
a	O
common	O
and	O
distressing	O
consequence	O
of	O
breast	O
cancer	I:C0678222
(	O
breast	B:C0678222
cancer	I:C0678222
)	O
treatment	O
.	O

Sexual	O
dysfunction	I:C0549622
is	O
a	O
common	O
and	O
distressing	O
consequence	O
of	O
breast	O
cancer	I:C0678222
(	O
breast	O
cancer	I:C0678222
)	O
treatment	B:C0087111
.	O

In	O
the	O
present	O
study	B:C2603343
,	O
we	O
investigated	O
the	O
sexual	O
functioning	I:C0278092
of	O
breast	O
cancer	I:C0678222
patients	O
and	O
its	O
association	O
with	O
women	O
's	I:C0043210
personal	O
characteristics	O
and	O
cancer	O
treatments	I:C0920425
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
sexual	B:C0278092
functioning	I:C0278092
of	O
breast	O
cancer	I:C0678222
patients	O
and	O
its	O
association	O
with	O
women	O
's	I:C0043210
personal	O
characteristics	O
and	O
cancer	O
treatments	I:C0920425
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
sexual	O
functioning	I:C0278092
of	O
breast	B:C0678222
cancer	I:C0678222
patients	O
and	O
its	O
association	O
with	O
women	O
's	I:C0043210
personal	O
characteristics	O
and	O
cancer	O
treatments	I:C0920425
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
sexual	O
functioning	I:C0278092
of	O
breast	O
cancer	I:C0678222
patients	O
and	O
its	O
association	B:C0004083
with	O
women	O
's	I:C0043210
personal	O
characteristics	O
and	O
cancer	O
treatments	I:C0920425
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
sexual	O
functioning	I:C0278092
of	O
breast	O
cancer	I:C0678222
patients	O
and	O
its	O
association	O
with	O
women	B:C0043210
's	I:C0043210
personal	O
characteristics	O
and	O
cancer	O
treatments	I:C0920425
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
sexual	O
functioning	I:C0278092
of	O
breast	O
cancer	I:C0678222
patients	O
and	O
its	O
association	O
with	O
women	O
's	I:C0043210
personal	O
characteristics	O
and	O
cancer	B:C0920425
treatments	I:C0920425
.	O

In	O
this	O
cross-sectional	B:C0010362
study	I:C0010362
,	O
sexual	O
function	I:C0278092
was	O
assessed	O
using	O
the	O
Female	O
Sexual	I:C4289276
Function	I:C4289276
Index	I:C4289276
(	O
Female	O
Sexual	I:C4289276
Function	I:C4289276
Index	I:C4289276
)	O
.	O

In	O
this	O
cross-sectional	O
study	I:C0010362
,	O
sexual	B:C0278092
function	I:C0278092
was	O
assessed	O
using	O
the	O
Female	O
Sexual	I:C4289276
Function	I:C4289276
Index	I:C4289276
(	O
Female	O
Sexual	I:C4289276
Function	I:C4289276
Index	I:C4289276
)	O
.	O

In	O
this	O
cross-sectional	O
study	I:C0010362
,	O
sexual	O
function	I:C0278092
was	O
assessed	O
using	O
the	O
Female	B:C4289276
Sexual	I:C4289276
Function	I:C4289276
Index	I:C4289276
(	O
Female	O
Sexual	I:C4289276
Function	I:C4289276
Index	I:C4289276
)	O
.	O

In	O
this	O
cross-sectional	O
study	I:C0010362
,	O
sexual	O
function	I:C0278092
was	O
assessed	O
using	O
the	O
Female	O
Sexual	I:C4289276
Function	I:C4289276
Index	I:C4289276
(	O
Female	B:C4289276
Sexual	I:C4289276
Function	I:C4289276
Index	I:C4289276
)	O
.	O

The	O
health	O
-	O
related	O
quality	O
of	O
life	O
(	O
HRQOL	O
)	O
was	O
measured	O
using	O
the	O
European	B:C1516985
Organization	I:C1516985
for	I:C1516985
Research	I:C1516985
and	I:C1516985
Treatment	I:C1516985
of	I:C1516985
Cancer	I:C1516985
(	O
European	O
Organization	I:C1516985
for	I:C1516985
Research	I:C1516985
and	I:C1516985
Treatment	I:C1516985
of	I:C1516985
Cancer	I:C1516985
)	O
QLQ	O
-	I:C3641780
C30	I:C3641780
and	O
its	O
breast	O
module	I:C0282574
BR	I:C0282574
-	I:C0282574
23	I:C0282574
.	O

The	O
health	O
-	O
related	O
quality	O
of	O
life	O
(	O
HRQOL	O
)	O
was	O
measured	O
using	O
the	O
European	O
Organization	I:C1516985
for	I:C1516985
Research	I:C1516985
and	I:C1516985
Treatment	I:C1516985
of	I:C1516985
Cancer	I:C1516985
(	O
European	B:C1516985
Organization	I:C1516985
for	I:C1516985
Research	I:C1516985
and	I:C1516985
Treatment	I:C1516985
of	I:C1516985
Cancer	I:C1516985
)	O
QLQ	O
-	I:C3641780
C30	I:C3641780
and	O
its	O
breast	O
module	I:C0282574
BR	I:C0282574
-	I:C0282574
23	I:C0282574
.	O

The	O
health	O
-	O
related	O
quality	O
of	O
life	O
(	O
HRQOL	O
)	O
was	O
measured	O
using	O
the	O
European	O
Organization	I:C1516985
for	I:C1516985
Research	I:C1516985
and	I:C1516985
Treatment	I:C1516985
of	I:C1516985
Cancer	I:C1516985
(	O
European	O
Organization	I:C1516985
for	I:C1516985
Research	I:C1516985
and	I:C1516985
Treatment	I:C1516985
of	I:C1516985
Cancer	I:C1516985
)	O
QLQ	B:C3641780
-	I:C3641780
C30	I:C3641780
and	O
its	O
breast	O
module	I:C0282574
BR	I:C0282574
-	I:C0282574
23	I:C0282574
.	O

The	O
health	O
-	O
related	O
quality	O
of	O
life	O
(	O
HRQOL	O
)	O
was	O
measured	O
using	O
the	O
European	O
Organization	I:C1516985
for	I:C1516985
Research	I:C1516985
and	I:C1516985
Treatment	I:C1516985
of	I:C1516985
Cancer	I:C1516985
(	O
European	O
Organization	I:C1516985
for	I:C1516985
Research	I:C1516985
and	I:C1516985
Treatment	I:C1516985
of	I:C1516985
Cancer	I:C1516985
)	O
QLQ	O
-	I:C3641780
C30	I:C3641780
and	O
its	O
breast	B:C0282574
module	I:C0282574
BR	I:C0282574
-	I:C0282574
23	I:C0282574
.	O

Of	O
the	O
235	O
participants	B:C0679646
approached	O
,	O
216	O
participants	O
were	O
included	O
in	O
the	O
study	O
.	O

Of	O
the	O
235	O
participants	O
approached	O
,	O
216	O
participants	B:C0679646
were	O
included	O
in	O
the	O
study	O
.	O

Of	O
these	O
,	O
63	O
patients	O
reported	O
no	O
sexual	O
activity	O
in	O
the	O
last	O
month	O
and	O
thus	O
were	O
analyzed	O
only	O
in	O
relation	O
to	O
the	O
sexual	B:C0023618
desire	I:C0023618
domain	O
of	O
Female	O
Sexual	I:C4289276
Function	I:C4289276
Index	I:C4289276
.	O

Of	O
these	O
,	O
63	O
patients	O
reported	O
no	O
sexual	O
activity	O
in	O
the	O
last	O
month	O
and	O
thus	O
were	O
analyzed	O
only	O
in	O
relation	O
to	O
the	O
sexual	O
desire	I:C0023618
domain	O
of	O
Female	B:C4289276
Sexual	I:C4289276
Function	I:C4289276
Index	I:C4289276
.	O

A	O
total	O
of	O
154	O
(	O
71.3	O
%	O
)	O
patients	O
were	O
classified	O
with	O
hypoactive	B:C0020594
sexual	I:C0020594
desire	I:C0020594
disorder	I:C0020594
(	O
hypoactive	O
sexual	I:C0020594
desire	I:C0020594
disorder	I:C0020594
)	O
.	O

A	O
total	O
of	O
154	O
(	O
71.3	O
%	O
)	O
patients	O
were	O
classified	O
with	O
hypoactive	O
sexual	I:C0020594
desire	I:C0020594
disorder	I:C0020594
(	O
hypoactive	B:C0020594
sexual	I:C0020594
desire	I:C0020594
disorder	I:C0020594
)	O
.	O

From	O
those	O
patients	O
reporting	O
sexual	O
activity	O
in	O
the	O
last	O
month	O
,	O
63.3	O
%	O
(	O
97	O
out	O
of	O
153	O
)	O
were	O
classified	O
with	O
sexual	B:C0549622
dysfunction	I:C0549622
.	O

Using	O
hierarchical	B:C0206031
logistic	I:C0206031
regression	I:C0206031
,	O
the	O
variance	O
explained	O
(	O
change	O
in	O
R	O
(	O
2	O
)	O
)	O
by	O
the	O
addition	O
of	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
and	O
mild	O
to	O
moderate	O
physical	O
activity	O
in	O
the	O
prediction	O
models	O
of	O
sexual	O
dysfunction	I:C0549622
and	O
hypoactive	O
sexual	I:C0020594
desire	I:C0020594
disorder	I:C0020594
were	O
6.8	O
and	O
7.2	O
%	O
,	O
respectively	O
.	O

Using	O
hierarchical	O
logistic	I:C0206031
regression	I:C0206031
,	O
the	O
variance	O
explained	O
(	O
change	O
in	O
R	O
(	O
2	O
)	O
)	O
by	O
the	O
addition	O
of	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
and	O
mild	O
to	O
moderate	O
physical	O
activity	O
in	O
the	O
prediction	O
models	O
of	O
sexual	O
dysfunction	I:C0549622
and	O
hypoactive	O
sexual	I:C0020594
desire	I:C0020594
disorder	I:C0020594
were	O
6.8	O
and	O
7.2	O
%	O
,	O
respectively	O
.	O

Using	O
hierarchical	O
logistic	I:C0206031
regression	I:C0206031
,	O
the	O
variance	O
explained	O
(	O
change	O
in	O
R	O
(	O
2	O
)	O
)	O
by	O
the	O
addition	O
of	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
)	O
and	O
mild	O
to	O
moderate	O
physical	O
activity	O
in	O
the	O
prediction	O
models	O
of	O
sexual	O
dysfunction	I:C0549622
and	O
hypoactive	O
sexual	I:C0020594
desire	I:C0020594
disorder	I:C0020594
were	O
6.8	O
and	O
7.2	O
%	O
,	O
respectively	O
.	O

Using	O
hierarchical	O
logistic	I:C0206031
regression	I:C0206031
,	O
the	O
variance	O
explained	O
(	O
change	O
in	O
R	O
(	O
2	O
)	O
)	O
by	O
the	O
addition	O
of	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
and	O
mild	O
to	O
moderate	O
physical	O
activity	O
in	O
the	O
prediction	O
models	B:C3161035
of	O
sexual	O
dysfunction	I:C0549622
and	O
hypoactive	O
sexual	I:C0020594
desire	I:C0020594
disorder	I:C0020594
were	O
6.8	O
and	O
7.2	O
%	O
,	O
respectively	O
.	O

Using	O
hierarchical	O
logistic	I:C0206031
regression	I:C0206031
,	O
the	O
variance	O
explained	O
(	O
change	O
in	O
R	O
(	O
2	O
)	O
)	O
by	O
the	O
addition	O
of	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
and	O
mild	O
to	O
moderate	O
physical	O
activity	O
in	O
the	O
prediction	O
models	O
of	O
sexual	B:C0549622
dysfunction	I:C0549622
and	O
hypoactive	O
sexual	I:C0020594
desire	I:C0020594
disorder	I:C0020594
were	O
6.8	O
and	O
7.2	O
%	O
,	O
respectively	O
.	O

Using	O
hierarchical	O
logistic	I:C0206031
regression	I:C0206031
,	O
the	O
variance	O
explained	O
(	O
change	O
in	O
R	O
(	O
2	O
)	O
)	O
by	O
the	O
addition	O
of	O
body	O
mass	I:C1305855
index	I:C1305855
(	O
body	O
mass	I:C1305855
index	I:C1305855
)	O
and	O
mild	O
to	O
moderate	O
physical	O
activity	O
in	O
the	O
prediction	O
models	O
of	O
sexual	O
dysfunction	I:C0549622
and	O
hypoactive	B:C0020594
sexual	I:C0020594
desire	I:C0020594
disorder	I:C0020594
were	O
6.8	O
and	O
7.2	O
%	O
,	O
respectively	O
.	O

Age	O
,	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
,	O
and	O
physical	O
activity	O
were	O
independently	O
associated	O
with	O
sexual	O
dysfunction	I:C0549622
and	O
hypoactive	O
sexual	I:C0020594
desire	I:C0020594
disorder	I:C0020594
.	O

Age	O
,	O
body	O
mass	I:C1305855
index	I:C1305855
,	O
and	O
physical	O
activity	O
were	O
independently	O
associated	O
with	O
sexual	B:C0549622
dysfunction	I:C0549622
and	O
hypoactive	O
sexual	I:C0020594
desire	I:C0020594
disorder	I:C0020594
.	O

Age	O
,	O
body	O
mass	I:C1305855
index	I:C1305855
,	O
and	O
physical	O
activity	O
were	O
independently	O
associated	O
with	O
sexual	O
dysfunction	I:C0549622
and	O
hypoactive	B:C0020594
sexual	I:C0020594
desire	I:C0020594
disorder	I:C0020594
.	O

Additionally	O
,	O
breast	B:C0678222
cancer	I:C0678222
patients	O
with	O
sexual	O
dysfunction	I:C0549622
reported	O
lower	O
scores	O
on	O
global	O
HRQOL	O
,	O
role	O
functioning	O
,	O
and	O
fatigue	O
.	O

Additionally	O
,	O
breast	O
cancer	I:C0678222
patients	O
with	O
sexual	B:C0549622
dysfunction	I:C0549622
reported	O
lower	O
scores	O
on	O
global	O
HRQOL	O
,	O
role	O
functioning	O
,	O
and	O
fatigue	O
.	O

Additionally	O
,	O
breast	O
cancer	I:C0678222
patients	O
with	O
sexual	O
dysfunction	I:C0549622
reported	O
lower	O
scores	O
on	O
global	O
HRQOL	O
,	O
role	O
functioning	O
,	O
and	O
fatigue	B:C0015672
.	O

Based	O
on	O
our	O
findings	B:C0243095
,	O
breast	O
cancer	I:C0678222
survivors	O
should	O
be	O
encouraged	O
to	O
practice	O
regular	O
physical	O
activity	O
and	O
to	O
lose	O
weight	O
in	O
order	O
to	O
avoid	O
sexual	O
dysfunction	I:C0549622
.	O

Based	O
on	O
our	O
findings	O
,	O
breast	B:C0678222
cancer	I:C0678222
survivors	O
should	O
be	O
encouraged	O
to	O
practice	O
regular	O
physical	O
activity	O
and	O
to	O
lose	O
weight	O
in	O
order	O
to	O
avoid	O
sexual	O
dysfunction	I:C0549622
.	O

Based	O
on	O
our	O
findings	O
,	O
breast	O
cancer	I:C0678222
survivors	O
should	O
be	O
encouraged	O
to	O
practice	B:C0032893
regular	O
physical	O
activity	O
and	O
to	O
lose	O
weight	O
in	O
order	O
to	O
avoid	O
sexual	O
dysfunction	I:C0549622
.	O

Based	O
on	O
our	O
findings	O
,	O
breast	O
cancer	I:C0678222
survivors	O
should	O
be	O
encouraged	O
to	O
practice	O
regular	O
physical	O
activity	O
and	O
to	O
lose	O
weight	O
in	O
order	O
to	O
avoid	O
sexual	B:C0549622
dysfunction	I:C0549622
.	O

However	O
,	O
future	O
clinical	B:C0008976
trials	I:C0008976
are	O
needed	O
to	O
confirm	O
these	O
findings	O
.	O

However	O
,	O
future	O
clinical	O
trials	I:C0008976
are	O
needed	O
to	O
confirm	O
these	O
findings	B:C0243095
.	O

